TNNI3 and myocardial infarction: The results of feMPI were consistent with those of cardiac troponin I (cTnI) in the first 24 h, which is a commonly used clinical indicator in MI/R, with dual-targeted probes identifying MI/R-induced cardiac injury ≥ 48 h earlier than echocardiography.